Literature DB >> 32191264

Dietary Potassium Intake and Risk of Chronic Kidney Disease Progression in Predialysis Patients with Chronic Kidney Disease: A Systematic Review.

Kelly Picard1,2, Maria Ines Barreto Silva1, Diana Mager1, Caroline Richard1.   

Abstract

The prevalence of chronic kidney disease (CKD) is increasing and dietary interventions may be a strategy to reduce this burden. In the general population, higher potassium intake is considered protective for cardiovascular health. Due to the risk of hyperkalemia in CKD, limiting potassium intake is often recommended. However, given that poor cardiovascular function can cause kidney damage, following a low-potassium diet may be deleterious for patients with CKD. The aim of this systematic review was to summarize the evidence on dietary potassium intake and CKD progression. Multiple databases were searched on 7 June 2019 and data were managed with Covidence. No intervention trials met the inclusion criteria. Eleven observational studies met the inclusion criteria (10 post hoc analyses, 1 retrospective cohort), representing 49,573 stage 1-5 predialysis patients with CKD from 41 different countries. Of the 11 studies, 6 studies reported exclusively on early CKD (stage 1-2), 4 studies separately reported analyses on both early and late (stage 3-5) CKD, and 2 studies reported exclusively on late CKD. A total of 9 studies reported risk of disease progression in early CKD; in 4 studies high potassium intake was associated with lower risk, while in 2 studies the low intake showed a higher progression of risk, and 3 studies reported no relation. In late CKD, results are mixed: 2 studies suggested benefit of higher potassium intake and 1 suggested benefit of lower potassium intake, whereas 3 studies were neutral. These results should be interpreted with caution, as considerations preventing firm conclusions include 1) the overall low range of dietary potassium intake, with all studies reporting an average intake below the 2004 Kidney Disease Outcomes Quality Initiatives guidelines, and 2) the method used to assess potassium intake in most studies (i.e., urine) in late stages of CKD. Ideally, well-controlled intervention studies are needed to understand how dietary potassium intake is linked to CKD progression.
Copyright © The Author(s) 2020.

Entities:  

Keywords:  chronic kidney disease; dietary intake; disease progression; potassium; pre-dialysis

Mesh:

Substances:

Year:  2020        PMID: 32191264      PMCID: PMC7360460          DOI: 10.1093/advances/nmaa027

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  40 in total

Review 1.  Dietary acid load: a novel nutritional target in chronic kidney disease?

Authors:  Julia J Scialla; Cheryl A M Anderson
Journal:  Adv Chronic Kidney Dis       Date:  2013-03       Impact factor: 3.620

Review 2.  Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for potassium and sodium intake.

Authors:  Laurence S Freedman; John M Commins; James E Moler; Walter Willett; Lesley F Tinker; Amy F Subar; Donna Spiegelman; Donna Rhodes; Nancy Potischman; Marian L Neuhouser; Alanna J Moshfegh; Victor Kipnis; Lenore Arab; Ross L Prentice
Journal:  Am J Epidemiol       Date:  2015-03-18       Impact factor: 4.897

3.  Urine Potassium Excretion, Kidney Failure, and Mortality in CKD.

Authors:  Amanda K Leonberg-Yoo; Hocine Tighiouart; Andrew S Levey; Gerald J Beck; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2016-05-24       Impact factor: 8.860

Review 4.  Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes.

Authors:  Sarah Gilligan; Kalani L Raphael
Journal:  Adv Chronic Kidney Dis       Date:  2017-09       Impact factor: 3.620

5.  Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial.

Authors:  Alex R Chang; Edgar R Miller; Cheryl A Anderson; Stephen P Juraschek; Melissa Moser; Karen White; Bobbie Henry; Caitlin Krekel; Susan Oh; Jeanne Charleston; Lawrence J Appel
Journal:  Am J Kidney Dis       Date:  2016-11-16       Impact factor: 8.860

6.  Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.

Authors:  Csaba P Kovesdy; Kunihiro Matsushita; Yingying Sang; Nigel J Brunskill; Juan J Carrero; Gabriel Chodick; Takeshi Hasegawa; Hiddo L Heerspink; Atsushi Hirayama; Gijs W D Landman; Adeera Levin; Dorothea Nitsch; David C Wheeler; Josef Coresh; Stein I Hallan; Varda Shalev; Morgan E Grams
Journal:  Eur Heart J       Date:  2018-05-01       Impact factor: 29.983

Review 7.  Potassium and health.

Authors:  Connie M Weaver
Journal:  Adv Nutr       Date:  2013-05-01       Impact factor: 8.701

8.  Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.

Authors:  Shin-ichi Araki; Masakazu Haneda; Daisuke Koya; Keiko Kondo; Sachiko Tanaka; Hisatomi Arima; Shinji Kume; Jun Nakazawa; Masami Chin-Kanasaki; Satoshi Ugi; Hiromichi Kawai; Hisazumi Araki; Takashi Uzu; Hiroshi Maegawa
Journal:  Clin J Am Soc Nephrol       Date:  2015-11-12       Impact factor: 8.237

9.  Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function.

Authors:  James P Lash; Alan S Go; Lawrence J Appel; Jiang He; Akinlolu Ojo; Mahboob Rahman; Raymond R Townsend; Dawei Xie; Denise Cifelli; Janet Cohan; Jeffrey C Fink; Michael J Fischer; Crystal Gadegbeku; L Lee Hamm; John W Kusek; J Richard Landis; Andrew Narva; Nancy Robinson; Valerie Teal; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 8.237

10.  Rationale and Design of a Randomized Placebo-Controlled Clinical Trial Assessing the Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease.

Authors:  Martin Gritter; Liffert Vogt; Stanley M H Yeung; Rosa D Wouda; Christian R B Ramakers; Martin H de Borst; Joris I Rotmans; Ewout J Hoorn
Journal:  Nephron       Date:  2018-06-29       Impact factor: 2.847

View more
  6 in total

1.  Saliva testing as a means to monitor therapeutic lithium levels in patients with psychiatric disorders: Identification of clinical and environmental covariates, and their incorporation into a prediction model.

Authors:  Georgia M Parkin; Michael J McCarthy; Soe H Thein; Hillary L Piccerillo; Nisha Warikoo; Douglas A Granger; Elizabeth A Thomas
Journal:  Bipolar Disord       Date:  2021-09-24       Impact factor: 5.345

2.  Potassium and fiber: a controversial couple in the nutritional management of children with chronic kidney disease.

Authors:  Ann Raes; Evelien Snauwaert; Sunny Eloot; Amina El Amouri; Kato Delva; Aurélie Foulon; Charlotte Vande Moortel; Koen Van Hoeck; Griet Glorieux; Wim Van Biesen; Johan Vande Walle
Journal:  Pediatr Nephrol       Date:  2022-01-07       Impact factor: 3.651

Review 3.  The "FIFTY SHADOWS" of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease.

Authors:  Gregorio Romero-González; Jordi Bover; Javier Arrieta; Davide Salera; Maribel Troya; Fredzzia Graterol; Pablo Ureña-Torres; Mario Cozzolino; Luca Di Lullo; Pietro E Cippà; Marina Urrutia; Javier Paúl-Martinez; Ramón Boixeda; José Luis Górriz; Jordi Ara; Antoni Bayés-Genís; Antonio Bellasi; Claudio Ronco
Journal:  J Clin Med       Date:  2022-07-08       Impact factor: 4.964

4.  Assessment of hypokalemia and clinical prognosis in Patients with COVID-19 in Yangzhou, China.

Authors:  Jiangtao Yin; Nana Yuan; Ziqiang Huang; Zhenkui Hu; Quanlei Bao; Zhenli Shao; Qiong Mei; Yong Xu; Wenli Wang; Dadong Liu; Li Zhao; Shengxia Wan
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

5.  Personalizing potassium management in patients on haemodialysis.

Authors:  Rosa D Wouda; Liffert Vogt; Ewout J Hoorn
Journal:  Nephrol Dial Transplant       Date:  2021-01-01       Impact factor: 5.992

6.  Commentary on the 2020 update of the KDOQI clinical practice guideline for nutrition in chronic kidney disease.

Authors:  Kelly Lambert; Su Bahceci; Harriet Harrison; Maria Chan; Nicole Scholes-Robertson; David W Johnson; Adela Yip; Andrea K Viecelli
Journal:  Nephrology (Carlton)       Date:  2022-02-03       Impact factor: 2.358

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.